Yin N, Yang FM, Qiao HT, Zhou Y, Duan SQ, Lin XC, Wu JY, Xie YP, He ZL, Sun MS, Li HJ. Neonatal rhesus monkeys as an animal model for rotavirus infection. World J Gastroenterol 2018; 24(45): 5109-5119 [PMID: 30568388 DOI: 10.3748/wjg.v24.i45.5109]
Corresponding Author of This Article
Research Domain of This Article
Virology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2018; 24(45): 5109-5119 Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5109
Neonatal rhesus monkeys as an animal model for rotavirus infection
Na Yin, Feng-Mei Yang, Hong-Tu Qiao, Yan Zhou, Su-Qin Duan, Xiao-Chen Lin, Jin-Yuan Wu, Yu-Ping Xie, Zhan-Long He, Mao-Sheng Sun, Hong-Jun Li
Na Yin, Hong-Tu Qiao, Yan Zhou, Xiao-Chen Lin, Jin-Yuan Wu, Yu-Ping Xie, Mao-Sheng Sun, Hong-Jun Li, Department of Molecular Biology, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming 650118, Yunnan Province, China
Feng-Mei Yang, Su-Qin Duan, Zhan-Long He, Primate Experimental Center of the Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming 650118, Yunnan Province, China
Author contributions: Yin N conceived the idea; Sun MS and Li HJ performed the experiments; Zhou Y, He ZL, and Li HJ contributed reagents and funds; Yang FM, Qiao HT, and Duan SQ performed the animal experiment; Wu JY performed all ELISA experiments; Zhou Y and Xie YP performed the viral RNA extraction and qRT-PCR assay experiments; Qiao HT and Lin XC performed the immunofluorescence experiments; Yin N, Yang FM, Zhou Y, and Li HJ drafted, read, corrected, and approved the manuscript; all authors reviewed the manuscript.
Supported bythe CAMS Initiative for Innovative Medicine, No. 2016-I2M-1-019; National Natural Science Foundation of China, No. 31700154; Major Science and Technology Special Project of Yunnan Province (Biomedicine), No. 2018ZF006; Science and Technology Project of Yunnan Province-general program, No. 2016FB034; Science and Technology Innovation Team Project of Kunming, No. 2016-2-R-07674; the Project of National Nonprofit Scientific Institutes Basic Scientific Service Fee, No. 2016ZX310179-4; Science and Technology Project of Yunnan Province, Key New Product Development, No. 2014BC008.
Correspondence author to: Hong-Jun Li, PhD, Academic Research, Department of Molecular Biology, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, No. 935, Jiaoling Road, Kunming 650118, Yunnan Province, China. lihj6912@163.com
Telephone: +86-871-68225391 Fax: +86-871-68225391
Received: August 14, 2018 Peer-review started: August 15, 2018 First decision: October 10, 2018 Revised: October 22, 2018 Accepted: November 7, 2018 Article in press: November 7, 2018 Published online: December 7, 2018 Processing time: 114 Days and 19.2 Hours
Core Tip
Core tip: Rotavirus (RV) is one of the main pathogens responsible for severe diarrhea in children under 5 years of age. Vaccine-induced immunity is an effective way to block RV disease. Nonhuman primates are the animals most closely related to humans and have advantages over non-primates as an animal model of RV diarrhea, so development of a nonhuman primate animal model of RV infection is needed to ensure the effectiveness and safety of these vaccines. Our current study has indicated that RV SA11 can lead to obvious diarrhea and pathological changes in the intestine of neonatal rhesus monkeys. The RV infection model we established is useful for us to further investigate the RV infection mechanism and the associated immune mechanisms in human infants and evaluate the cross protection of potential HRV vaccine candidates.
